NCT06630104View on ClinicalTrials.gov

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

December 16, 2025

Study Completion Date

December 16, 2025

Conditions
Lymphoproliferative DisorderMultiple Myeloma
Interventions
PROCEDURE

Biospecimen Collection

Undergo hair, buccal, and saliva sample collection

PROCEDURE

Bone Marrow Aspiration

Undergo bone marrow aspiration

OTHER

Electronic Health Record Review

Ancillary studies

PROCEDURE

Follow-Up

Undergo CFU

OTHER

Genetic Counseling

Receive genetic counselor consultation

OTHER

Genetic Testing

Undergo sequencing analysis

Trial Locations (7)

54601

RECRUITING

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

RECRUITING

Mayo Clinic Health System-Eau Claire Clinic, Eau Claire

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

56001

RECRUITING

Mayo Clinic Health System-Mankato, Mankato

56007

RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06630104 - Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) | Biotech Hunter | Biotech Hunter